|
基于“炎癌学说”探讨中医“治未病”理论在宫颈癌中的应用
|
Abstract:
研究发现炎症与肿瘤的发生关系密切,炎症调节因子在慢性炎症的催化下形成炎症微环境,致使相关部位恶性肿瘤的发生、发展和恶化。根据相关流行病学调查显示,宫颈癌为女性常见的恶性肿瘤之一,相关实验证明慢性宫颈炎症的前期存在与宫颈癌的发病存在关联。本文基于“炎癌学说”探讨炎症与肿瘤存在联系的同时,也为宫颈慢性炎症与宫颈癌之间的相关性提供了依据,参考相关临床研究及实验观察发现中医药对宫颈慢性炎症的防治存在优势,符合中医“治未病”理论对疾病的防治理念,为进一步研究炎症与宫颈癌之间的转化通路提供了理论基础,也为临床防治宫颈癌提供了新思路。
Studies have found that inflammation is closely related to the occurrence of tumors. Inflammation regulators form an inflammatory microenvironment under the catalysis of chronic inflammation, which leads to the occurrence, development and deterioration of malignant tumors in related areas. According to the relevant epidemiological survey, cervical cancer is one of the common malignant tumors in women, and relevant experiments have proved that the existence of chronic cervical inflammation in the early stage is related to the incidence of cervical cancer. Based on the theory of inflammation and cancer, this paper not only discusses the relationship between inflammation and tumor, but also provides a basis for the correlation between chronic cervical inflammation and cervical cancer. Referring to relevant clinical studies and experimental observations, it is found that traditional Chinese medicine has advantages in the prevention and treatment of chronic cervical inflammation, which is in line with the concept of disease prevention and treatment in the theory of traditional Chinese medicine. It provides a theoretical basis for further research on the transformation pathway between inflammation and cervical cancer, and also provides a new idea for clinical prevention and treatment of cervical cancer.
[1] | 蔡会龙, 原伟光, 孙惠昕. 全球及我国宫颈癌流行现状及防治策略[J]. 临床肿瘤学杂志, 2023, 28(1): 90-93. |
[2] | Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660 |
[3] | Babic, A., Schnure, N., Neupane, N.P., Zaman, M.M., Rifai, N., Welch, M.W., et al. (2018) Plasma Inflammatory Cytokines and Survival of Pancreatic Cancer Patients. Clinical and Translational Gastroenterology, 9, e145. https://doi.org/10.1038/s41424-018-0008-5 |
[4] | Wong, C.H., Iskandar, K.B., Yadav, S.K., Hirpara, J.L., Loh, T. and Pervaiz, S. (2010) Simultaneous Induction of Non-Canonical Autophagy and Apoptosis in Cancer Cells by Ros-Dependent ERK and JNK Activation. PLOS ONE, 5, e9996. https://doi.org/10.1371/journal.pone.0009996 |
[5] | 王季青, 周春慧. 宫颈癌危险因素的流行病学调查分析[J]. 中外医学研究, 2014, 12(3): 79-80. |
[6] | 何林蓉. 宫颈癌危险因素的流行病学调查分析[J]. 大家健康(中旬版), 2015(3): 28. |
[7] | Ghosh, I., Muwonge, R., Mittal, S., Banerjee, D., Kundu, P., Mandal, R., et al. (2017) Association between High Risk Human Papillomavirus Infection and Co-Infection with Candida Spp. and Trichomonas Vaginalis in Women with Cervical Premalignant and Malignant Lesions. Journal of Clinical Virology, 87, 43-48. https://doi.org/10.1016/j.jcv.2016.12.007 |
[8] | 范君艳, 严烩利, 史巧. 从伏邪理论探讨宫颈HPV感染的防治[J]. 浙江中医药大学学报, 2022, 46(9): 997-1001. |
[9] | 陈嘉怡, 邵昱玮, 单原子, 等. 中药治疗宫颈癌的用药规律及作用机制分析[J]. 中国性科学, 2023, 32(5): 135-139. |
[10] | 陈皇珍, 姚美玉, 吴效科, 等. 治疗妇科肿瘤经验介绍[J]. 辽宁中医杂志, 2010, 37(1): 25-27. |
[11] | 陈顺泰, 花宝金. 中医药防治宫颈癌人乳头瘤病毒感染的研究进展[J]. 吉林中医药, 2020, 40(2): 275-277. |
[12] | 田虎, 田思胜. 恶性肿瘤血液高凝状态的中医药治疗[J]. 中医杂志, 2019, 60(7): 572-575. |
[13] | 覃晓洵, 钱麟. 中医药治疗宫颈人乳头瘤病毒感染的临床研究进展[J]. 河北中医, 2018, 40(10): 1596-1600. |
[14] | 孙立新. 妇科肿瘤的中医病机及论治浅析[J]. 山东医学高等专科学校学报, 2019, 41(3): 221-222. |
[15] | Mleko, M., Pitynski, K., Pluta, E., Czerw, A., Sygit, K., Karakiewicz, B., et al. (2021) Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies—State of the Art. Cancer Management and Research, 13, 5491-5508. https://doi.org/10.2147/cmar.s312828 |
[16] | 窦莉伶, 付春云. “炎症与肿瘤”的研究进展及对肿瘤防治的启示[J]. 国际检验医学杂志, 2012, 33(10): 1234-1236. |
[17] | Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. https://doi.org/10.1038/nature07205 |
[18] | Murdoch, C., Muthana, M., Coffelt, S.B. and Lewis, C.E. (2008) The Role of Myeloid Cells in the Promotion of Tumour Angiogenesis. Nature Reviews Cancer, 8, 618-631. https://doi.org/10.1038/nrc2444 |
[19] | Tamas, A.G., Shuiping, T., Timothy, C., 等. 慢性炎症、肿瘤微环境与癌变[J]. 中国肺癌杂志, 2009, 12(9): 1022-1031. |
[20] | 王嫱, 宋殿荣. 宫颈炎症状态对HPV感染的影响研究[J]. 国际妇产科学杂志, 2023, 50(6): 627-631. |
[21] | Ylitalo, N., Josefsson, A., Melbye, M., et al. (2000) A Prospective Study Showing Long-Term Infection with Human Papillomavirus 16 before the Development of Cervical Carcinoma in Situ. Cancer Research, 60, 6027-6032. |
[22] | 梁艳华, 毕超, 梁景耀, 等. 不同亚型HPV感染与女性宫颈疾病的相关性[J]. 分子诊断与治疗杂志, 2017, 9(3): 196-200. |
[23] | Ye, Y., Wang, X., Jeschke, U. and von Schönfeldt, V. (2020) COX-2-PGE2-EPs in Gynecological Cancers. Archives of Gynecology and Obstetrics, 301, 1365-1375. https://doi.org/10.1007/s00404-020-05559-6 |
[24] | 李毅. 宫颈病毒感染与宫颈癌相关因素研究[J]. 中华医院感染学杂志, 2008, 18(8): 1107-1108. |
[25] | Friel, G., Liu, C.S., Kolomeyevskaya, N.V., Hampras, S.S., Kruszka, B., Schmitt, K., et al. (2015) Aspirin and Acetaminophen Use and the Risk of Cervical Cancer. Journal of Lower Genital Tract Disease, 19, 189-193. https://doi.org/10.1097/lgt.0000000000000104 |
[26] | 黄晓澜, 王冬冬, 杨清. 阴道炎症与宫颈癌发生的相关性研究进展[J]. 中国微生态学杂志, 2019, 31(4): 485-489. |
[27] | Boscolo-Rizzo, P., Pawlita, M. and Holzinger, D. (2016) From HPV-Positive towards HPV-Driven Oropharyngeal Squamous Cell Carcinomas. Cancer Treatment Reviews, 42, 24-29. https://doi.org/10.1016/j.ctrv.2015.10.009 |
[28] | 潘静. 生殖道细菌感染和HPV感染与宫颈癌关系的研究[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2013. |
[29] | 刘璐, 程桂丽, 刘世兰, 等. 宫颈癌患者血清Th1、Th2细胞因子表达水平及意义[J]. 癌症进展, 2017, 15(2): 156-158. |
[30] | 张婵, 孙媛, 刘铭, 等. HPV病毒感染与宫颈病变发生发展关系的研究进展[J]. 中国微生态学杂志, 2016, 28(7): 861-864. |
[31] | Parida, S. and Mandal, M. (2014) Inflammation Induced by Human Papillomavirus in Cervical Cancer and Its Implication in Prevention. European Journal of Cancer Prevention, 23, 432-448. https://doi.org/10.1097/cej.0000000000000023 |
[32] | Adefuye, A., Katz, A.A. and Sales, K.J. (2014) The Regulation of Inflammatory Pathways and Infectious Disease of the Cervix by Seminal Fluid. Pathology Research International, 2014, 1-9. https://doi.org/10.1155/2014/748740 |
[33] | Deivendran, S., Marzook, K.H. and Radhakrishna Pillai, M. (2014) The Role of Inflammation in Cervical Cancer. In: Aggarwal, B.B., Sung, B. and Gupta, S.C., Eds., Inflammation and Cancer, Springer, 377-399. https://doi.org/10.1007/978-3-0348-0837-8_15 |
[34] | Tilborghs, S., Corthouts, J., Verhoeven, Y., Arias, D., Rolfo, C., Trinh, X.B., et al. (2017) The Role of Nuclear Factor-Kappa B Signaling in Human Cervical Cancer. Critical Reviews in Oncology/Hematology, 120, 141-150. https://doi.org/10.1016/j.critrevonc.2017.11.001 |
[35] | 欧阳婧, 万小平, 万菁. 妇科肿瘤与炎症[J]. 国际妇产科学杂志, 2011, 38(2): 115-119. |
[36] | 唐凌, 孙鼎, 喻晓, 等. 基于“治未病”理论的中医适宜技术防治慢性阻塞性肺病稳定期患者的研究进展[J]. 世界中医药, 2021, 16(5): 849-854. |
[37] | 孙有智, 罗畅, 赵益. “治未病”思想在疾病预防应用中的问题及对策[J]. 中国中医基础医学杂志, 2016, 22(12): 1633-1634. |
[38] | 高阳, 守芳漾, 万弘扬, 等. 基于“治未病”探析结直肠癌肝转移的研究进展[J]. 中医药临床杂志, 2023, 35(9): 1831-1836. |
[39] | 曹丹丹, 任青玲, 孙凤丹. 治未病在HR-HPV持续性感染防治中的应用[J]. 四川中医, 2018, 36(1): 37-39. |
[40] | 葛严萍, 张文怡. 扶正祛邪方在妇科肿瘤化疗中的应用[J]. 辽宁中医杂志, 2002, 29(12): 712. |
[41] | 李秀, 狄广慈, 戴任金铭, 等. 任青玲教授从湿邪论治宫颈持续性人乳头瘤病毒感染经验[J]. 辽宁中医杂志, 2024, 51(6): 17-19. |
[42] | 于明玥, 杨婕, 张丽娟. 刘瑞芬教授基于“内外合邪”治疗HPV感染经验浅析 [J]. 时珍国医国药, 2023, 34(4): 970-971. |
[43] | 程双, 彭财英, 潘玲玲, 等. 中药土茯苓的现代研究进展[J]. 江西中医药, 2021, 52(3): 69-76. |
[44] | 吴朗杰, 赵春燕, 战丽彬. 基于网络药理学和分子对接研究白花蛇舌草和半枝莲药对治疗宫颈癌的作用机制[J]. 中草药, 2021, 52(4): 1049-1058. |
[45] | 徐学麟, 周欢珍, 高雅洁, 等. 参苓白术散治疗脾虚型慢性宫颈炎的临床疗效及作用机制[J]. 中药材, 2022, 45(9): 2261-2263. |
[46] | Tjendra, Y., Al Mana, A.F., Espejo, A.P., Akgun, Y., Millan, N.C., Gomez-Fernandez, C., et al. (2020) Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Archives of Pathology & Laboratory Medicine, 144, 1465-1474. https://doi.org/10.5858/arpa.2020-0471-sa |
[47] | van Gerven, C., Eid, K., Krüger, T., Fell, M., Kendoff, D., Friedrich, M., et al. (2020) Serum C-Reactive Protein and WBC Count in Conservatively and Operatively Managed Bacterial Spondylodiscitis. Journal of Orthopaedic Surgery, 29, Article 230949902096829. https://doi.org/10.1177/2309499020968296 |
[48] | 高琦, 赵玉玲, 张荣荣, 等. 加味仙方活命饮对腹腔镜宫颈癌根治术后预防感染的疗效评价[J]. 甘肃医药, 2023, 42(3): 217-219. |
[49] | 杨曼生, 黄红杨, 张秀莲, 等. 中药外洗治疗慢性宫颈炎的临床效果观察[J]. 实用妇科内分泌电子杂志, 2020, 7(21): 56-57. |
[50] | 陈敏. 保妇康栓治疗宫颈糜烂合并HPV感染临床疗效观察[J]. 中国医药科学, 2018, 8(12): 43-45. |
[51] | 杜惠兰, 魏绍斌, 谈勇, 等. 苦参凝胶临床应用指导意见[J]. 中草药, 2020, 51(8): 2088-2094. |
[52] | 王转红, 王峥, 刘欢, 等. 康复新液联合保妇康栓治疗慢性宫颈炎伴HPV感染疗效观察[J]. 中医学报, 2018, 33(8): 1576-1579. |
[53] | 孙淑梅, 贾丹, 宋清霞, 等. 易黄汤联合保妇康栓对HR-HPV持续感染患者中医证候及免疫因子的影响[J]. 中华养生保健, 2023, 41(24): 25-28. |
[54] | 吴冬红, 徐冬艳, 邓冬梅, 等. 完带汤加减联合康妇凝胶治疗子宫颈炎合并高危HPV感染疗效观察[J]. 山西中医, 2023, 39(3): 45-46. |